Healthcare provider profile · identity verified

Kathryn Lee Maxwell, D.O.

Osteopathic Manipulative Medicine · EUGENE, OR · NPI 1972827913

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	133
Levothyroxine Sodium	Levothyroxine Sodium	328	87
Lisinopril	Lisinopril	294	91
Losartan Potassium	Losartan Potassium	255	74
Metoprolol Tartrate	Metoprolol Tartrate	254	65
Amlodipine Besylate	Amlodipine Besylate	253	74
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	224	41
Rosuvastatin Calcium	Rosuvastatin Calcium	222	68
Gabapentin	Gabapentin	213	54
Trazodone Hcl	Trazodone Hcl	183	56
Potassium Chloride	Potassium Chloride	154	44
Furosemide	Furosemide	151	39
Metformin Hcl Er	Metformin Hcl	149	49
Simvastatin	Simvastatin	149	39
Albuterol Sulfate Hfa	Albuterol Sulfate	145	55
Pantoprazole Sodium	Pantoprazole Sodium	144	48
Duloxetine Hcl	Duloxetine Hcl	141	29
Metformin Hcl	Metformin Hcl	130	39
Pradaxa	Dabigatran Etexilate Mesylate	118	29
Metoprolol Succinate	Metoprolol Succinate	109	31
Oxycodone Hcl	Oxycodone Hcl	100	22
Mirtazapine	Mirtazapine	96	23
Atenolol	Atenolol	90	27
Glipizide	Glipizide	89	28
Sertraline Hcl	Sertraline Hcl	89	30
Pravastatin Sodium	Pravastatin Sodium	88	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	78	23
Alendronate Sodium	Alendronate Sodium	76	23
Fluoxetine Hcl	Fluoxetine Hcl	74	26
Tamsulosin Hcl	Tamsulosin Hcl	71	18
Buspirone Hcl	Buspirone Hcl	67	20
Spironolactone	Spironolactone	67	23
Ozempic	Semaglutide	64	suppressed
Valsartan	Valsartan	62	17
Hydrochlorothiazide	Hydrochlorothiazide	61	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	17
Warfarin Sodium	Warfarin Sodium	61	18
Humulin N	Insulin Nph Human Isophane	59	16
Triamcinolone Acetonide	Triamcinolone Acetonide	59	33
Clopidogrel	Clopidogrel Bisulfate	57	13
Baclofen	Baclofen	56	17
Memantine Hcl	Memantine Hcl	56	12
Escitalopram Oxalate	Escitalopram Oxalate	53	23
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	52	13
Venlafaxine Hcl Er	Venlafaxine Hcl	51	15
Alvesco	Ciclesonide	50	20
Fluticasone Propionate	Fluticasone Propionate	50	16
Jardiance	Empagliflozin	49	18
Omeprazole	Omeprazole	49	16
Ondansetron Odt	Ondansetron	47	19
Xarelto	Rivaroxaban	47	15
Azelastine Hcl	Azelastine Hcl	46	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Carvedilol	Carvedilol	40	12
Citalopram Hbr	Citalopram Hydrobromide	40	12
Nifedipine Er	Nifedipine	40	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	39	15
Propranolol Hcl	Propranolol Hcl	39	13
Wixela Inhub	Fluticasone Propion/Salmeterol	39	15
Prednisone	Prednisone	38	19
Spiriva Respimat	Tiotropium Bromide	38	12
Bupropion Xl	Bupropion Hcl	37	14
Donepezil Hcl	Donepezil Hcl	37	12
Allopurinol	Allopurinol	34	suppressed
Estradiol	Estradiol	32	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	32	11
Ipratropium Bromide	Ipratropium Bromide	32	17
Olanzapine	Olanzapine	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	11
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Famotidine	Famotidine	28	suppressed
Topiramate	Topiramate	28	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	28	suppressed
Humulin R	Insulin Regular, Human	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Meloxicam	Meloxicam	27	14
Clobetasol Propionate	Clobetasol Propionate	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Ketoconazole	Ketoconazole	23	14
Tramadol Hcl	Tramadol Hcl	23	suppressed
Pregabalin	Pregabalin	22	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Eliquis	Apixaban	19	suppressed
Torsemide	Torsemide	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Lorazepam	Lorazepam	18	11
Montelukast Sodium	Montelukast Sodium	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Finasteride	Finasteride	17	suppressed
Nystatin	Nystatin	17	12
Promethazine Hcl	Promethazine Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Naproxen	Naproxen	15	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	15	15
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Cefuroxime	Cefuroxime Axetil	14	12
Divalproex Sodium	Divalproex Sodium	14	suppressed
Hydrocortisone	Hydrocortisone	14	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Celecoxib	Celecoxib	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error